Vaxart, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
VXRT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
170 Harbor Way, Suite 300, South San Francisco, CA

Insiders trading volume in the past year

Vaxart, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Edward B. Berg SVP, General Counsel $396K Mar 24, 2025
Phillip E. Lee Chief Financial Officer $360K Mar 24, 2025
Andrei Floroiu President, Chief Exec Officer, Director $343K Mar 17, 2023
Sean Tucker SVP, Chief Scientific Officer $337K Mar 28, 2025
James F. Cummings Chief Medical Officer $314K Mar 28, 2025
Michael J. Finney Director $295K Jun 13, 2025
Jeroen Grasman Chief Financial Officer $151K May 19, 2025
Todd C. Davis Director $95.3K Aug 4, 2022
Kevin Finney Director $75.8K +$61.9K +448% Jul 17, 2025
Steven Lo President, Chief Exec Officer, Director $49K +$49K May 19, 2025
Robert A. Yedid Director $44.8K Jun 11, 2024
W. Mark Watson Director $42.2K +$4.05K +10.6% Jul 29, 2025
Elaine J. Heron Director $23.8K Jun 13, 2025
David E. Wheadon Director $19.6K Jun 13, 2025
Julie M. Cherrington Director $4.71K Aug 4, 2022
Fuad Ahmad Interim CFO $3.79K Jun 22, 2022
Karen J. Wilson Director Jun 16, 2021
Wouter Latour Director May 6, 2021
Margaret Echerd SVP, Principal Accntng Officer Nov 30, 2021

Recent Insider Transactions by Companies or Individuals for Vaxart, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.